IGF-1 LR3 (Insulin-Like Growth Factor 1 Long-R3 Variant) – 1MG Research-Use-Only Peptide

IGF-1 LR3 is a modified variant of insulin-like growth factor 1, characterized by a substitution of the C-terminal arginine residues with lysine and arginine (LR3) for enhanced stability and reduced immunogenicity. This peptide is commonly explored in scientific research to investigate its potential effects on cellular signaling pathways, muscle growth, and tissue regeneration under controlled experimental conditions.

IGF-1 LR3 plays a central role in mediating growth, metabolism, and repair processes in biological systems. Originally isolated from human plasma, IGF-1 is a key regulator of cellular functions mediated through its interaction with IGF-1 receptors. The LR3 modification is frequently studied in preclinical models due to its ability to prolong peptide stability in circulation, making it a valuable tool for research focused on peptide pharmacokinetics and biological activity.

Research Overview

IGF-1 LR3 has been extensively investigated in laboratory settings as a research tool to probe the mechanisms underlying growth hormone signaling and tissue-specific responses. Its modified structure allows for enhanced stability, which can be crucial when assessing long-term physiological effects in animal or cell culture models. Due to its structural modifications, IGF-1 LR3 is often used in studies aiming to dissect receptor-mediated pathways, tissue-specific responses, and potential therapeutic mechanisms in disease models.

Key Research Focus Areas

• Muscle Growth and Regeneration:
  IGF-1 LR3’s effects on muscle protein synthesis and repair are frequently studied in preclinical research to understand its role in conditions such as aging, muscle atrophy, or trauma-related injuries.
• Tissue Regeneration and Healing:
  Research in animal models has explored its potential in promoting wound healing, cartilage repair, and bone regeneration through modulation of extracellular matrix remodeling and cellular proliferation.
• Metabolic and Endocrine Signaling:
  Investigations often examine its impact on glucose metabolism, lipid homeostasis, and insulin sensitivity in experimental settings to assess its broader physiological implications.
• Pharmacokinetics and Stability:
  Studies evaluate the peptide’s half-life, receptor binding affinity, and systemic distribution to optimize its use in research applications where prolonged activity is desired.
• Toxicology and Immunogenicity:
  Research includes safety assessments to determine potential adverse effects, including immune responses or off-target interactions, which are critical for determining its suitability in controlled experimental designs.

This product is intended solely for use in academic or institutional research environments under the supervision of qualified professionals. It is not intended for diagnostic, therapeutic, or cosmetic applications.

For research use only. Not for human or animal consumption. Any distribution or use in violation of this disclaimer is strictly prohibited and may result in legal consequences. Always adhere to institutional guidelines and regulatory requirements applicable to your research facility.